Lifemd (LFMD) closed at $2.13 on October 23, 2026, down 1.8% from the previous close, on volume of 396,597 shares (30-day average 757,301).
Data as of October 23, 2026.
23-Oct-2026
LifeMD to Report Third Quarter 2026 Financial Results on November 9
Globe Newswire (Tue, 20-Oct 4:05 PM ET)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Globe Newswire (Tue, 22-Sep 5:01 PM ET)
AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD
PRNewswire (Tue, 15-Sep 9:01 AM ET)
UPDATE - LifeMD Reports Second Quarter 2026 Results
Globe Newswire (Wed, 5-Aug 7:45 PM ET)
LifeMD Reports Second Quarter 2026 Results
Globe Newswire (Wed, 5-Aug 4:11 PM ET)
Market Chameleon (Tue, 10-Mar 6:32 AM ET)
LifeMD Appoints Dr. Tara Scott as Ambassador to Bolster Comprehensive Women’s Health Program
Market Chameleon (Wed, 22-Oct 5:36 AM ET)
LifeMD Broadens Access to Ozempic for $499 Per Month Through Direct Collaboration with Novo Nordisk
Market Chameleon (Tue, 30-Sep 4:46 AM ET)
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Lifemd trades on the NASDAQ stock market under the symbol LFMD.
As of October 23, 2026, LFMD stock price declined to $2.13 with 396,597 million shares trading.
LFMD has a beta of 1.31, meaning it tends to be more sensitive to market movements. LFMD has a correlation of 0.06 to the broad based SPY ETF.
LFMD has a market cap of $102.78 million. This is considered a Micro Cap stock.
Last quarter Lifemd reported $47 million in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.08.
In the last 3 years, LFMD traded as high as $15.84 and as low as $2.10.
The top ETF exchange traded funds that LFMD belongs to (by Net Assets): VTI, IWM, VXF, KOMP, VTWO.
LFMD has underperformed the market in the last year with a price return of -65.8% while the SPY ETF gained +14.3%. LFMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.0% and -19.0%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
LFMD support price is $2.09 and resistance is $2.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMD shares will trade within this expected range on the day.